Lilly And EVA Pharma Sign Voluntary License Deal For Baricitinib In Africa

The Deal Covers 49 Low- To Middle-Income Countries In Africa

 
• By Urtė Fultinavičiūtė

Eli Lilly will provide a know-how manufacturing guide to EVA Pharma, as it prepares to manufacture and sell baricitinib by 2026.

Pills and capsules over a map of Africa continent with national flags of countries
• Source: Shutterstock

More from Deals

More from Pink Sheet